Table of Content

  1. Introduction
    • Definition of Pediatric Brain Tumor Market
    • Scope of the Report
  2. Methodology
    • Executive Summary
    • Market Overview
    • Market Definition and Segmentation
  3. Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
    • Porter's Five Forces Analysis
    • PESTEL Analysis
  4. Pediatric Brain Tumor Market, By Types
    • Gliomas
      • Astrocytoma
      • Malignant Gliomas
      • Others
    • Mixed Neuronal-Glial Tumors
      • Ganglioglioma
      • Subependymal Giant Cell Tumor
      • Pleomorphic Xanthoastrocytoma
      • Others
    • Embryonal Tumors
      • Primitive Neuroectodermal Tumor (PNET)
      • Atypical Teratoid/Rhabdoid Tumor
      • Others
    • Choroid Plexus Papilloma/Carcinoma
    • Tumors Arising From Non-Neuroepithelial Tissue
      • Craniopharyngioma
      • Pineal Region Tumors
      • Other
    • Meningeal Tumors
    • Others
  5. Pediatric Brain Tumor Market, By Diagnosis
    • Physical Exam
    • Imaging Tests
      • Magnetic Resonance Imaging (MRI) Scan
        • Magnetic Resonance Angiography (MRA)
        • Magnetic Resonance Spectroscopy (MRS)
        • Magnetic Resonance Perfusion
        • Functional MRI (FMRI)
        • Others
      • Computed Tomography (CT) Scan
      • Positron Emission Tomography (PET) Scan
      • Angiogram
      • Others
    • Brain Or Spinal Cord Tumor Biopsy
      • Stereotactic Needle Biopsy
      • Craniotomy
      • Others
    • Lumbar Puncture (Spinal Tap)
    • Blood And Urine Tests
    • Others
  6. Pediatric Brain Tumor Market, By Treatment
    • Surgery
      • Surgical Biopsy
      • Resection (Removal)
      • Shunt Placement/Revision
      • Others
    • Therapies
      • Radiation Therapy
      • Chemotherapy
        • Carboplatin
        • Carmustine (BCNU)
        • Cisplatin
        • Cyclophosphamide
        • Etoposide
        • Lomustine (CCNU)
        • Methotrexate
        • Temozolomide
        • Thiotepa
        • Vincristine
        • Others
    • Targeted Therapy
    • Others
  7. Pediatric Brain Tumor Market, By End User
    • Hospitals And Clinics
    • Medical Research Centers
    • Academic Institutes
    • Others
  8. Pediatric Brain Tumor Market, By Geography
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • Saudi Arabia
      • United Arab Emirates
      • South Africa
      • Rest of Middle East & Africa
  9. Competitive Landscape
  10. Company Profiles
    • Abbott. (US)
      • Company Overview
      • Product Portfolio and Description
      • Key Highlights
      • Financial Overview
    • AbbVie Inc. (US)
    • Akorn Inc. (US)
    • Agios Inc. (US)
    • Baxter (US)
    • Bayer AG (US)
    • Epizyme Inc. (US)
    • Novartis AG (Switzerland)
    • Mylan N.V. (US)
  11. Conclusion and Future Outlook
  12. Appendix
    • Research Methodology
    • About the Pharmanucleus
  13. Disclaimer


Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.